Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for those with a history of Type 2 Diabetes and Hypertension and established cardiovascular disease.
Hypertension & Type 2 Diabetes
Age Range:
18
Gender:
Male and Female
Location:
Media, Pennsylvania
About the Study
This study is looking to compare how well the investigational injection acts with existing medication as compared to the medication by itself, in reducing risk of cardiovascular disease and preventing heart failure in at risk patients.
What to Expect
- Study may last up to 30-51 months, including screening time.
- 9 In-person visits at our clinic for medication and checkups.
- 5 Telephone calls from our clinic for checkups.
- A follow-up period after your last dose to monitor health and symptoms
Qualifications
You may qualify if you are:
- Are over 18 years of age.
- Have Hypertension currently being treated with medication.
- Currently on medication for Cardiovascular Disease (Coronary Artery Disease, or Cerebrovascular Disease, or Peripheral Artery Disease)
FEATURED STUDIES
Heart Failure Prevention Study
Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at
Weight & Wellness Research Study Interest
Researchers are evaluating an investigational oral treatment for adults who are overweight and may be at risk of developing certain
Flu Prevention Study Interest List
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
General Anxiety Disorder Study
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a
Uncontrolled COPD Study
Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a
MDD Study
Adults 18 to 65 years of age with Major Depressive Disorder (MDD) may qualify for a clinical research study evaluating